My wife and I tried the HenryMeds version of sublingual tirzepatide and got absolutely no effect from it. They probably are not using any kind of special delivery system (liposomes, etc).
1 Like
I have been taking 3 mg Rybelsus for a couple of weeks. It is the most strongly bitter obnoxious medication ā you have to really concentrate hard to get it swallowed fast to minimize the obnoxious taste. I cannot imagine holding any of this under your tongue. What am I missing?
3 Likes
You make a really good point, @Deborah_Hall . I remember that nasty taste when I was on Rybelsus. Maybe some strong counter-flavor added to the sublingual pill could help?
Confirmation by this pharmacist that my reasoning is correct: Comments - The Compounding Loophole - by Scott Alexander
So anyone buying Rybelsus 14 mg for ~$100 from Europe, India or Latin America could theoretically get the equivalent of the lowest Ozempic dose for $2/month. 
I donāt think anyone should do this, but it just shows how insane the pharma margins are before generic entry and how cheap generic Ozempic will be in 2031ā¦
Regarding the taste: I tried Rybelsus twice and didnāt notice anything particular. If the taste is terrible you could block your nose? Or add some food for taste?
By the way in the US thereās now generic liraglutide as an alternative: Victoza: Generic Ozempic-Like GLP-1 Drug Now Available in U.S.
4 Likes
SGLT2i seem to be as good (if not better?) as dulaglutide in this emulated trial: SodiumāGlucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia: A Population-Based Cohort Study 2024
Results: Overall, 12 489 patients initiating SGLT2 inhibitor treatment (51.9% dapagliflozin and 48.1% empagliflozin) and 1075 patients initiating dulaglutide treatment were included. In the matched cohort, over a median follow-up of 4.4 years, the primary outcome event occurred in 69 participants in the SGLT2 inhibitor group and 43 in the dulaglutide group. The estimated risk difference was ā0.91 percentage point (95% CI, ā2.45 to 0.63 percentage point), and the estimated risk ratio was 0.81 (CI, 0.56 to 1.16).
Limitation: Residual confounding is possible; there was no adjustment for hemoglobin A1c levels or duration of diabetes; the study is not representative of newer drugs, including more effective GLP-1 RAs; and the onset of dementia was not measured directly.
3 Likes
I donāt know how you knew about the generic liraglutide before I did!
So with a GoodRx coupon, 3 pens 18 mg/3mL at Walgreens is $334.29. So at full dose of 1.8 mg per day, that would be a 30 day supply.
Not cheap, but is much better than the usual $1000 monthly.
4 Likes
In addition to the awful taste, there are the gastro effects. You are not āsupposedā to feel much at this non-therapeutic starter dose but I am here to report that indeed you do. Have been on the starter 3 mg tabs 2+weeks and really feeling it. Have stepped back to every other day ā need recovery days and also stretching supply til I can see the endocrinologist. But GLPās are not approved or covered for Type1 DM so I will most likely continue to buy from India.
But ā the price is pretty great. $5 for a 7 mg and $5.50 for a 14 mg. If you stay on the 7 mg which compares to lowest dose of injectable sema, and split the 14 mg pills, ā as adssx said --about $2/month. per adssx āI donāt think anyone should do this . . . .ā ----why not? what am I missing? I would rather have the injectable but if ordering from India, thinking of transit, refrigeration requirements ?, shortages ā
Interesting that youāre using it for T1D. This paper from 2 days ago shows potential: Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double-blind, placebo-controlled trial
I said this because I donāt want to imply that itās safe. I think no one knows.
I like that paper.
āThere is only one study of dulaglutide and cognition in humans, but it was a very large study and produced convincing results.ā āThat very large study of dulaglutide was a randomized, double-blind placebo-controlled trial of subjects aged ā„50 yearsā
What do you think?
Questions: If used as a prophylactic, do you have to take dulaglutide forever or is one several-month course adequate?
Trulicity dulaglutide by Eli Lilly is available at a reasonable price from India. Since dulaglutide is a peptide do you think it might not travel well from India?
Thank you @DrFraser . Anyone interested in Monjuaro (or other fixed dose GLP1 pen like semaglutide, etc.) should check this out. Please note the amount drawn up in the syringe was 0.1 mL which is 3 mg when using the 15 mg pen.
2 Likes
Interesting, I wonder if thatās why my estradiol has been coming back high for awhile now. Iāve been using GLP1ās for the last couple years on and off. SHBG slightly high too, but all other markers and hormones look same or improved.
In rodent models of AD so not sure itās worth much butā¦ The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice 2024
1 Like
This paper is a few years old, but it makes sense that combining SGLT2i with GLP-1 agonists would be at least additive in their potential weight loss and health benefits:
After starting tirzepatide 2.5 mg weekly in early August, I stopped my empagliflozin since Iād expected the empa to be superfluous, but now Iām going to try āmicro dosingā the tirz (1mg weekly) and going back on empagliflozin 25mg daily. This should minimize side effects from the tirzepatide (increased heart rate, lowered HRV, sleep disruption).
I never really lost any weight from empa because my appetite simply increased to compensate for the glucose excretion. The low dose tirzepatide should take care of that.
Benefits of this approach: dramatically decreased cost of GLP agonist therapy due to low doses (while SGLT2i drugs are cheap from India), greatly decreased risk of side effects, additive/synergistic health and weight loss benefits.
3 Likes
The scientists Iāve seen say its still too early to tell this (slowing aging):
4 Likes
Yes I think the SGLT2i + GLP-1RA combo is the way, check the ORs here itās very impressive: Intermittent (oral) Rybelsus / Semaglutide use in healthy individuals? - #215 by adssx
Unfortunately, Novo Nordisk stopped its single pill dapagliflozin + oral semaglutideā¦
In terms of effects:
- Subadditive for HbA1C
- Additive for weight loss
- Synergistic (i.e. supra-additive) for BP
Paper just published suggests additive effects for eGFR: Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis
Open questions:
- Lipids
- Liver
- Neuroprotection
- Muscle mass
- Mood disorders
- Arrhythmia
And as you said, can you increase the safety with a low-dose combination? 
3 Likes
On the same topic: Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study 2024
24 out of 26 randomised participants completed the study (13 participants randomised to dulaglutide first and 13 to placebo first). No change in the MGH-SFQ was observed after four weeks of dulaglutide versus placebo (estimated difference 0.58 [95% CI ā0.83 to 2.00], p-value = 0.402). Hormones of the hypothalamic-pituitary-gonadal axis (estimated differences: total testosterone (nmol/l) 0.9 [95% CI ā1.5 to 3.3], FSH (IU/l) ā0.2 [95% CI ā0.3 to 0.0] and LH (IU/l) ā0.8 [95% CI ā1.5 to 0.0]) as well as sperm parameters all remained in the normal range without significant differences between the treatments. No severe adverse events occurred.
In this study of healthy men, we found no evidence of negative impacts of a four-week treatment with the widely used GLP-1 receptor agonist dulaglutide on sexual desire, hypothalamic-pituitary-gonadal axis hormones or sperm parameters.
1 Like
Thanks for seeing my friend, who successfully used CVS coupon for rapamycin for prices much better than shipped from India!
3 Likes
No problem - it was a pleasure, and thank you for the referral.
Itās usually a nice experience for someone who is used to feeling a little on the fringe to meet with someone who is completely used to all the things they do and can do, and is supportive.
Interestingly, I had someone go to CVS with a GoodRx coupon which I think was going to be about $45 for 30 mg, and they had an āinternalā CVS coupon that put it down to $27. This is my first time seeing a U.S. pharmacy sell at <$1/mg.
4 Likes
Itās an animal model (actually two) and we know that these models are not great at representing neurodegenerative diseases. Still, despite robust glucose control and weight loss, neither semaglutide nor tirzepatide improved cognition, behavioral testing, plaque burden or neuroinflammation in these mice.
Is BBB crossing needed (e.g. exenatide or dulaglutide)? Are the models bad? 
Several papers suggest that GLP-1RA might lower osteoarthritis pain besides weight loss, hereās the latest one (from India): Dual effects of dulaglutide on glycemic control and knee osteoarthritis pain in elderly patients with Type 2 diabetes
Elderly T2DM patients diagnosed with bilateral knee OA on conventional OA treatment for at least 3 months were studied for their glycemic metrics, OA pain scores and NSAID consumption at baseline, 3 months and 6 months.
Significant improvements in glycemic control were observed, HbA1c decreased from 8.7% to 6.5% over 6 months. Pain scores, NSAID, body weight and BMI showed substantial reductions over time. Positive correlation (r = 0.73, p < 0.001) was found between glycemic control and pain reduction.
Conclusion: Dulaglutide improves glycemic control, knee joint OA pain and weight management in elderly patients with T2DM.
The lower NSAID consumption is the most impressive results to me. TBCā¦
1 Like